Long non-coding RNA LASSIE regulates shear stress sensing and endothelial barrier function by Stanicek, Laura et al.
ARTICLE
Long non-coding RNA LASSIE regulates shear
stress sensing and endothelial barrier function
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Ilka Wittig 5, Jos van Rijssel 6, Jaap Diederik van Buul 6, Anke van Bergen 1, Alina Klems7,
Anne Sophie Ramms7, Ferdinand Le Noble7, Patrick Hofmann2,8, Robert Szulcek9, ShengPeng Wang 10,
Stefan Offermanns 10, Meryem Seda Ercanoglu11,12, Hyouk-Bum Kwon13, Didier Stainier13,
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Blood vessels are constantly exposed to shear stress, a biomechanical force generated by
blood flow. Normal shear stress sensing and barrier function are crucial for vascular
homeostasis and are controlled by adherens junctions (AJs). Here we show that AJs are
stabilized by the shear stress-induced long non-coding RNA LASSIE (linc00520). Silencing of
LASSIE in endothelial cells impairs cell survival, cell-cell contacts and cell alignment in the
direction of flow. LASSIE associates with junction proteins (e.g. PECAM-1) and the inter-
mediate filament protein nestin, as identified by RNA affinity purification. The AJs component
VE-cadherin showed decreased stabilization, due to reduced interaction with nestin and the
microtubule cytoskeleton in the absence of LASSIE. This study identifies LASSIE as link
between nestin and VE-cadherin, and describes nestin as crucial component in the endo-
thelial response to shear stress. Furthermore, this study indicates that LASSIE regulates
barrier function by connecting AJs to the cytoskeleton.
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B lood vessels are lined by endothelial cells (ECs) forming aphysical barrier that separates blood from the surroundingtissue. The maintenance of EC-cell junctions is thus crucial
for endothelial homeostasis and consequently requires tight reg-
ulation and continuous adaptation. Hemodynamic shear stress—
a biomechanical force generated by blood flow—is a main reg-
ulator of this process. ECs exposed to laminar shear stress (LSS)
display transcription of atheroprotective genes, many of these are
dependent on Kruppel-like factor 2 (KLF2) and 4 (KLF4)1–3.
Concurrently, high LSS promotes EC alignment and strengthens
EC-cell junctions4, thus contributing to endothelial barrier
function5,6. Aberrant interactions between ECs cause increased
permeability and tissue edema, a common cause of many
pathological conditions7,8.
EC junctions comprise tight junctions (TJs), adherens junc-
tions (AJs) and gap junctions. TJs and AJs contribute to endo-
thelial barrier integrity9,10. Both junctional structures are formed
between neighboring cells by homophilic assembly of trans-
membrane proteins that in turn are anchored to the cytoskeleton
via intracellular adaptor proteins. Vascular endothelial (VE)-
cadherin as main component of AJs directly interacts with β- and
γ-catenin (also called junctional plakoglobin). Both catenins bind
α-catenin which is responsible for AJs stabilization by associating
to actin11–13. Another adhesion protein present in EC junctions is
platelet endothelial cell adhesion molecule (PECAM-1). Like VE-
cadherin, PECAM-1 binds to catenins, namely β- and γ-catenin,
and might exert similar biological functions14. Moreover, VE-
cadherin and PECAM-1 have been reported to form a mechan-
osensory complex together with VE growth factor receptor 2 that
is responsible for shear stress sensing in ECs15. Besides actin,
intermediate filaments (IF) represent cytoskeletal structures that
are described to be involved in that process16. Microtubules in
contrast have been described as cytoskeletal component indis-
pensable for normal endothelial barrier function17. However, the
purpose of the various connections of junction proteins to the
cytoskeleton is not fully understood.
A vast majority (80%) of the human genome is transcribed into
noncoding RNA while only 2–3% codes for proteins, as reported
by the encyclopedia of DNA elements project18. Noncoding
RNAs are frequently classified according to their size into small
(<200 nt) and long noncoding RNAs (lncRNAs, >200 nt)19. A
well-studied example of small noncoding RNAs is the micro-
RNAs. In contrast, the larger long noncoding RNAs are more
poorly characterized. Yet, several studies propose diverse
mechanisms of action in a wide range of biological processes. The
ability of lncRNAs to bind proteins and nucleic acids enables
them to act as guidance molecules. One example is the involve-
ment of lncRNAs in the regulation of gene expression by
recruiting chromatin modifiers or transcription factors20,21. Many
lncRNAs are exported from the nucleus and exert their function
posttranscriptionally in the cytoplasm or specific organelles,
where they are known to regulate mRNA stability and protein
translation22,23.
LncRNAs were previously shown to exert regulatory func-
tions in the endothelium, while several lncRNAs have emerged
as epigenetic regulators in ECs24–27. Nonetheless, the invol-
vement of lncRNA transcripts in the regulation of shear stress
sensing in ECs remains unexplored. In this study, we
identify the shear stress-induced lncRNA LASSIE (LncRNA
activated by shear stress in the endothelium) and characterize
its role in EC function. We show that LASSIE stabilizes EC
junctions through interaction with junctional and cytoskeletal
proteins to promote the association of the cytoskeleton to AJs.
LASSIE plays a crucial role in junction stability and barrier
function in ECs and is indispensable for normal shear stress
sensing.
Results
LASSIE is a shear stress-induced lncRNA. Using previously
published RNA sequencing analysis of human umbilical vein
endothelial cells (HUVECs) exposed to LSS (20 dyn/cm2 for 72 h)
and cultured at static condition28, we identified the lncRNA
linc00520, exhibiting a 34-fold induction in shear stress-exposed
HUVECs compared with static cells, as validated by qRT-PCR
(Fig. 1a). The noncoding potential of linc00520 was confirmed by
comparison with the directly upstream and downstream located
protein coding genes PELI2 and KTN1 using the computational
prediction tool CPAT29 (Supplementary Fig. 1a). This lncRNA is
expressed in a wide range of ECs isolated from different vascular
beds (Supplementary Fig. 1b) and was subsequently termed
LASSIE, given its strong and consistent induction by prolonged
LSS (Fig. 1a). In contrast, LASSIE expression is not significantly
affected by oscillatory shear stress, as compared with static con-
ditions (Supplementary Fig. 1c). Furthermore, LASSIE expression
is induced by shear stress in different vascular ECs, such as
microvascular ECs, pulmonary arterial ECs, and aortic ECs, as
well as by different shear stress magnitudes (Supplementary
Fig. 1d–g). The role of the transcription factor KLF2 in LASSIE
expression was analyzed, as KLF2 is a known inducer of many
shear stress-responsive genes in ECs1,2. Lentiviral overexpression
of KLF2 in static conditions resulted in a ninefold upregulation of
LASSIE (Fig. 1b). Furthermore, silencing of KLF2 using short
hairpin RNA diminishes the induction of LASSIE in LSS-exposed
HUVECs (Fig. 1c). These results demonstrate a partly KLF2-
dependent expression of LASSIE upon exposure to LSS.
Next, we aimed to identify functional homologues of LASSIE
in vivo. The genomic LASSIE sequence is poorly conserved
between human, mouse, and zebrafish. The zebrafish BC091967
and the human LASSIE gene share a homologous locus and a
similar exon architecture (Fig. 1d). Thus, the functional
conservation of this gene was addressed by assessing shear stress
responsiveness in zebrafish. To this end, morpholinos targeting
cardiac troponin T2 (Tnnt2) were used in zebrafish that
consequently lack blood flow, as previously described30. We used
fli1a:EGFP zebrafish that express EGFP in ECs and separated ECs
from non-ECs by FACS-sorting. ECs from Tnnt2a morphants
exhibited greatly reduced expression of BC091967 and klf2a
compared with control morphants (Fig. 1e, Supplementary Fig. 2).
These results show that the zebrafish transcript BC091967 from
the locus homologous to human LASSIE is shear stress responsive
as well.
LASSIE regulates endothelial cell function. To determine the
functional role of LASSIE in ECs, we performed loss-of-function
experiments in cells. Nuclear–cytoplasmic fractionation revealed
a predominant cytoplasmic localization of LASSIE when com-
pared with nuclear enriched lncRNA MALAT-131 and cyto-
plasmic enriched protein-coding mRNA ribosomal protein lateral
stalk subunit P10 (RPLP0) (Fig. 2a). Two different knockdown
strategies were applied using locked nucleic acid (LNA) GapmeRs
and siRNAs. These oligonucleotides were designed according to
LASSIE transcript characterization by 5′ and 3′ RACE (rapid
amplification of cDNA ends) (Supplementary Fig. 3a). Both
knockdown strategies resulted in a significant reduction of total
LASSIE levels by more than 80% (Fig. 2b). The functional role of
LASSIE was subsequently analyzed by several in vitro assays.
Silencing of LASSIE induced apoptosis as assessed by caspase-3/7
activity and annexin V binding (Fig. 2c, d, Supplementary
Fig. 3b), both indicators for apoptosis. Decreased proliferation of
LASSIE-silenced HUVECs was observed by determining EdU
incorporation and cell counting at distinct time points after
transfection (Fig. 2e, f). In contrast, cell migration was not
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significantly affected (Supplementary Fig. 3c–e). Concomitantly,
angiogenic spouting of LASSIE-silenced HUVECs was disturbed,
demonstrated by a decrease in total sprout outgrowth and an
increase in discontinuous sprout formation, both under basal
condition and after stimulation with VEGF (Fig. 2g–i). Impaired
angiogenic sprouting due to insufficient stalk cell function in
LASSIE-silenced ECs implies a crucial impact of this lncRNA on
EC function, likely involving cell–cell interactions or cell survival.
LASSIE interacts with proteins of endothelial junctional
complexes. Next, we analyzed the underlying molecular
mechanism causing the observed biological phenotype. As LAS-
SIE does not greatly influence global gene expression (Supple-
mentary Fig. 4a), we aimed to identify putative protein
interaction partners by RNA-antisense (AS) purification. To this
end, LASSIE accessibility was examined by RNase H digestion
and oligonucleotide binding was subsequently validated by qRT-
PCR, as previously described27 (Supplementary Fig. 4b, c). Using
a 3′ desthiobiotin-TEG labeled 2′ O-Me-RNA LASSIE-AS oligo-
nucleotide yielded a ninefold enrichment of LASSIE compared
with a non-targeting control oligonucleotide (Fig. 3a, b). LASSIE
was purified by streptavidin pulldown from HUVECs lysate,
using physiological isolation conditions (150 mM NaCl) without
crosslinking. Co-purified proteins were identified by mass spec-
trometry (MS) (Fig. 3c). Although there is some noise due to
unspecific RNA-protein (RNP) interactions, this analysis revealed
a significant enrichment of PECAM-1 and γ-catenin (Supple-
mentary 1), compared with a non-targeting control oligonu-
cleotide. LASSIE binding to PECAM-1 was validated by
crosslinking immunoprecipitation (CLIP) resulting in a sig-
nificant enrichment of LASSIE co-immunoprecipitated with an
anti-PECAM-1 antibody compared with isotype control (IgG)
(Fig. 3d). Gene ontology analysis revealed LASSIE interacting
proteins as components of EC junctions and the protein pro-
cessing machinery in the endoplasmic reticulum (ER) (Supple-
mentary 2). The subcellular distribution of LASSIE and the
interaction with identified proteins were consequently analyzed
by RNA in situ hybridization. A branched DNA (bDNA) tech-
nique32 was applied using 20 oligonucleotides distributed along
the LASSIE transcript ensuring specificity and enhancement of
the RNA signal. A distinct LASSIE signal was observed co-
localizing with junction proteins VE-cadherin, PECAM-1, γ-
catenin and the ER marker calreticulin (Fig. 3e, f), consistent with
the data obtained from LASSIE-AS purification. Specificity of the
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Fig. 1 LASSIE is a shear stress-induced lncRNA. a, b HUVECs were exposed to laminar shear stress (20 dyn/cm2) or cultured at static condition. Changes
in LASSIE and KLF2 expression by different types of shear stress were assessed by qRT-PCR. Expression values are relative to static condition and
normalized to GAPDH mRNA. KLF2 is shown as a shear stress-induced positive control. a Cells were exposed to shear stress for the indicated time periods
(n= 3; two-way ANOVA; static 48 h vs. shear 48 h: p < 0.0001 (LASSIE); static 72 h vs. shear 72 h: p < 0.0001 (LASSIE); p= 0.0001 (KLF2)). Gray line
depicts static control levels. b The effect of lentiviral-mediated (Lenti) KLF2 induction on LASSIE expression in static HUVECs was analyzed by qRT-PCR.
Expression is relative to mock-transduced cells and normalized to RPLP0 mRNA (n= 4; Mann–Whitney test; LASSIE: p= 0.0286; KLF2: p= 0.0286).
c KLF2-dependent expression of LASSIE was analyzed by lentiviral-mediated shRNA knockdown of KLF2 in HUVECs exposed to laminar shear stress
(20 dyn/cm2 for 72 h), RNA levels were assessed by qRT-PCR. Expression is relative to mock-transduced cells and normalized to GAPDH mRNA (n= 5;
two-way ANOVA, LASSIE: shctr static vs. shctr shear: p < 0.0001; shctr shear vs. shKLF2 shear: p < 0.0001). d The KTN1-LASSIE-PELI2 locus is conserved
between human and zebrafish. e Fli1a:EGFP embryos were injected with 4 ng tnnt2a and control (ctr) morpholino (MO) to asses shear stress-dependent
expression of zebrafish LASSIE (BC091967). Seventy-two hours postfertilization GFP positive cells were sorted by FACS and subsequently analyzed by qRT-
PCR. Expression values are relative to ctr MO treated zebrafish. klf2a is shown as a shear stress-induced positive control, expression is normalized to elf1a
mRNA (n= 223 (ctr MO) n= 234 (tnnt2a MO) over three independent experiments; one-sample t-test: klf2a: p= 0.0002 BC091967: p= 0.014) (*p <
0.05; **p < 0.01; ***p < 0.001).
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LASSIE probes was confirmed in LASSIE-silenced HUVECs,
displaying a significantly decreased RNA signal (Supplementary
Fig. 4d, e). Taken into account that PECAM-1, γ-catenin, and
VE-cadherin display a rather membrane-associated localization,
the latter partly overlapping with the ER signal, these results
indicate that most of the LASSIE transcript is located close to the
ER or the cell plasma membrane.
LASSIE regulates endothelial barrier integrity and the response
to laminar shear stress. As LASSIE interacting proteins PECAM-
1 and γ-catenin are part of endothelial junctional complexes and
thus contribute to endothelial barrier function, we analyzed the
influence of LASSIE in this process using the electric cell-
substrate impedance sensing (ECIS) system33 (Fig. 4a). Strikingly,
LASSIE knockdown significantly decreased (Fig. 4b), whereas its
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Fig. 2 LASSIE regulates endothelial cell function. a Distribution of LASSIE was analyzed by qRT-PCR in nuclear and cytoplasmic fractions of HUVECs,
MALAT-1 is shown as a nuclear enriched lncRNA and RPLP0 as a cytoplasmic enriched mRNA (n= 3; one-way ANOVA; nuclear fraction: MALAT-1 vs.
LASSIE: p < 0.0001; cytoplasmic fraction: RPLP0 vs. LASSIE: p < 0.0001). b–g HUVECs were transfected with GapmeR (gap) or siRNA (si) targeting LASSIE
or a respective control (ctr) sequence, subsequent experiments were performed 48 h post transfection. b Relative expression of LASSIE was assessed by
qRT-PCR, expression is relative to control cells and normalized to RPLP0 mRNA (siRNA: n= 4; gapmeR: n= 3, one-way ANOVA; all depicted comparisons:
p < 0.0001). c, d Apoptosis was assessed by caspase-3/7 activity relative to control cells (H2O2 is shown as a positive control; n= 5; one-way ANOVA;
compared with gap ctr: p= 0.0075 (gap LASSIE 1) p= 0.0324 (gap LASSIE 2)) and flow cytometry of annexin V stained cells (n= 3; one-way ANOVA;
compared with gap ctr: p < 0.0001 (gap LASSIE 1); p= 0.0285 (gap LASSIE 2)). e, f Proliferation was determined by EdU incorporation (n= 4; one-way
ANOVA; compared with gap ctr: p= 0.0257 (gap LASSIE 1); p= 0.0321 (gap LASSIE 2)) and cell counting at the indicated time points post transfection
(n= 4; two-way ANOVA; compared with gap ctr; 48 h: p= 0.0009 (gap LASSIE 1); p= 0.023 (gap LASSIE 2); 72 h: p= 0.0018 (gap LASSIE 1); p= 0.0141
(gap LASSIE 2)). Both experiments are shown relative to control cells. g In vitro sprouting was analyzed under basal conditions and VEGF (50 ng/ml)
stimulation. Representative images are shown, red arrows indicate discontinuous sprouts. Scale bars are 100 µm (Six independent experiments with more
than four spheroids per group were analyzed). h, i Quantification of cumulative and discontinuous sprout length measurements (two-way ANOVA,
compared with gap ctr; n= 62 (gap ctr), n= 41 (gap LASSIE 1), n= 63 (gap LASSIE 2), n= 49 (gap ctr +VEGF), n= 41 (gap LASSIE 1 +VEGF), n= 57 (gap
LASSIE 1 +VEGF); cumulative: −VEGF: p= 0.0258 (gap LASSIE 1); p < 0.0001 (gap LASSIE 2); +VEGF: p= 0.0005 (gap LASSIE 1); p < 0.0001 (gap
LASSIE 2); discontinuous: −VEGF: p= 0.0236 (gap LASSIE 1); p < 0.0001 (gap LASSIE 2); +VEGF: p= 0.0195 (gap LASSIE 1); p < 0.0001 (gap LASSIE 2))
(*p < 0.05; **p < 0.01; ***p < 0.001).
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lentiviral-mediated overexpression (Supplementary Table 3,
Supplementary Fig. 5a) increased resistance of the HUVEC
monolayer (Fig. 4c). In accordance, endothelial barrier function
analyzed by Transwell assays confirmed a decrease in HUVEC
monolayer integrity after knockdown of LASSIE (Fig. 4d). This
effect is independent of caspase-induced apoptosis, as treatment
with the pan-caspase inhibitor Z-VAD-FMK did not prevent
barrier disruption due to silencing of LASSIE (Supplementary Fig.
5b, c). However, the expression of junction proteins PECAM-1
and VE-cadherin was neither changed on RNA level nor on cell
surface protein level (Supplementary Fig. 5d, e). Furthermore, the
gap area between shear stress-exposed cells was increased after
knockdown of LASSIE as quantified by immunostaining (Fig. 4e,
f). Since AJs in general and PECAM-1 in particular are crucially
involved in sensing shear stress16,34, we next determined whether
LASSIE is required for proper endothelial shear stress response.
Assessment of EC morphology revealed disturbed cell alignment
in the direction of flow after silencing LASSIE (Fig. 4g). One of
the earliest detectable responses to the onset of shear stress is the
influx of calcium ions. We therefore measured calcium influx
upon exposure to shear stress pulses of 3, 10, and 15 dyn/cm2 and
detected a decrease in calcium influx after knockdown of LASSIE,
as compared with control cells (Fig. 4h). These results indicate a
detrimental effect due to LASSIE silencing on barrier function
and shear stress sensing in ECs.
LASSIE stabilizes adherens junctions by regulating the asso-
ciation to the cytoskeleton. The direct interaction of LASSIE
with AJ proteins as well as its impact on shear stress sensing led
us to hypothesize a direct influence of LASSIE on the composition
of endothelial junctional complexes. To address this hypothesis,
a b d
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Fig. 3 LASSIE interacts with proteins of endothelial junctional complexes. a Schematic depiction of the antisense (AS) affinity purification of endogenous
RNA-protein complexes. b Endogenous LASSIE-protein complexes were captured by RNA-antisense purification. LASSIE was targeted by a desthiobiotin-
coupled 2′O-Me-RNA-antisense oligonucleotide (AS) by incubation with HUVEC cell lysates. RNA-protein complexes were captured using streptavidin
beads. Biotin elution and subsequent qRT-PCR detected LASSIE enrichment compared with a control desthiobiotin-coupled 2′O-Me-RNA oligonucleotide,
enrichment is shown as percentage of the input fraction (n= 5; ratio paired t-test; p= 0.0315). c Biotin elutions from LASSIE-antisense purification were
analyzed by mass spectrometry (n= 5). d HUVEC cell lysates were incubated with an anti-PECAM-1 antibody and isotype control (IgG) for crosslinking
RNA immunoprecipitation (CLIP). Enrichment of co-purified LASSIE RNA was detected by qRT-PCR and shown as percentage of the input fraction (n= 3;
ratio paired t-test: p= 0.0332). CLIP efficiency was analyzed by western blotting (WB) with an anti-PECAM-1 antibody, 1% of the lysate was used as a
control and was detected separately. Representative WB is depicted. e Subcellular localization of LASSIE (white) was analyzed by ViewRNA® in situ
hybridization in HUVECs exposed to laminar shear stress (20 dyn/cm2 for 72 h). Cells were immunostained for VE-cadherin (green), PECAM-1 (green),
the ER marker CALR (red), and γ-catenin (red). Nuclei were labeled with DAPI (blue). Representative images are shown. Scale bars are 25 µm. Arrows
indicate LASSIE co-localization with the ER (pointing to the bottom left) and the membrane (pointing to the top right). Boxes correspond to zoomed images
of the respective composite image. Scale bars are 5 µm. f Co-localization of LASSIE with co-stained proteins was analyzed for DAPI (n= 27), CALR (n= 14;
p < 0.0001), VE-cadherin (n= 14; p < 0.0001), PECAM-1 (n= 13), and γ-catenin (n= 13) from one experiment (one-way ANOVA; compared with nuclei)
(*p < 0.05; **p < 0.01; ***p < 0.001).
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LASSIE-silenced HUVECs were subjected to co-
immunoprecipitation using an anti-VE-cadherin antibody (Sup-
plementary Fig. 6a). Differentially associated proteins were
identified by MS. This analysis revealed a significantly decreased
association of cytoskeleton-linked proteins with VE-cadherin
after silencing of LASSIE (Fig. 5a, Supplementary 3). Merging the
earlier identified LASSIE interacting proteins with differentially
VE-cadherin associated proteins resulted in an overlap of five
proteins (Supplementary Fig. 6b). One of those is nestin, a type
VI IF, which associates 2.4-fold less with VE-cadherin in the
absence of LASSIE. Co-immunoprecipitation of VE-cadherin
using an anti-nestin antibody was performed in the presence/
absence of RNase A. Treatment with RNase A significantly
decreased the interaction of nestin and VE-cadherin
(Supplementary Fig. 6c), demonstrating an RNA-sensitive
protein–protein interaction. More specifically, LASSIE binding
to nestin was validated by CLIP resulting in a significant
enrichment of LASSIE co-immunoprecipitated with an anti-
nestin antibody compared with isotype control (IgG) (Fig. 5b).
The specific enrichment of nestin by LASSIE-AS purification was
confirmed in LASSIE-silenced cells, as nestin enrichment was
decreased in the absence of LASSIE, demonstrated by MS and
western blotting (Fig. 5c, Supplementary Fig. 6d, Supplementary
4). Decreased interaction of VE-cadherin and nestin after
knockdown of LASSIE was confirmed by proximity ligation assay
(PLA) where the PLA signal is a measure of protein–protein
interactions (Fig. 5d, e). We therefore hypothesized that the
association of nestin IF to AJs is controlled by LASSIE. To test
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Fig. 4 LASSIE regulates endothelial barrier integrity and the response to laminar shear stress. a Schematic depiction of the electrical cell-substrate
impedance sensing (ECIS) technique to assess endothelial barrier function. b, c The effect of GapmeR-mediated (gap) silencing of LASSIE (n= 4; one-way
ANOVA; compared with gap ctr: p= 0.0002 (gap LASSIE 1); p= 0.0023 (gap LASSIE 2)) and lentiviral-induced (Lenti) LASSIE overexpression (n= 7;
unpaired t-test: p= 0.0121) on HUVECs barrier integrity was assessed by ECIS at 400 Hz. d–g HUVECs were treated with anti-LASSIE or control (ctr)
GapmeR (gap). d Cells were seeded in Transwells and HRP passage through the endothelial monolayer was assessed by absorption measurements
(450 nm) and shown as percentage of total HRP (n= 3; one-way ANOVA; compared with gap ctr: p= 0.007 (gap LASSIE 1); p= 0.0403 (gap LASSIE 2)).
e–g Cells were exposed to laminar shear stress (20 dyn/cm2 for 48 h) and immunostained for VE-cadherin (red), PECAM-1 (green), and F-Actin (white).
Nuclei were stained with DAPI (blue). Representative images are shown. Scale bars are 25 µm. f Quantification of the gap area between neighboring cells
(n= 10 (gap ctr), n= 13 (gap LASSIE 1; p= 0.0425), n= 14 (gap LASSIE 2; p= 0.0226) over two independent experiments; one-way ANOVA (compared
with gap ctr)). g Shear stress-induced cell alignment was quantified by determining the angle of the major cell axis (n= 1217 (gap ctr), n= 636 (gap LASSIE
1; p= 0 < 0.0001), n= 1159 (gap LASSIE 2; p < 0.0001)) over two independent experiments; one-way ANOVA (compared with gap ctr). h Fluo-4-loaded
HUAECs were transfected with anti-LASSIE or control (ctr) siRNA (si) and exposed to indicated shear stress rates. Intracellular calcium [Ca2+]I was
determined as fluorescence intensity (RFU, relative fluorescence units). Representative graph is shown. Induction of [Ca2+]I was quantified (n= 4; one-
way ANOVA; compared with si ctr; 3 dyn: p= 0.0033 (si LASSIE 1); p= 0.0428 (si LASSIE 2); 10 dyn: p= 0.0141 (si LASSIE 1); p= 0.0412 (si LASSIE 2);
15 dyn: p= 0.0714 (si LASSIE 1); p= 0.0465 (si LASSIE 2)) (*p < 0.05; **p < 0.01; ***p < 0.001).
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Fig. 5 LASSIE stabilizes the association of the cytoskeleton to adherens junctions. a HUVEC lysates of anti-LASSIE or control (ctr) siRNA (si) treated
cells were used for immunoprecipitation by incubation with an anti-VE-cadherin antibody. Captured proteins were analyzed by mass spectrometry. LFQ
ratios of si LASSIE (n= 4) to si ctr (n= 5) are plotted against the respective IBAQ values. Proteins with significantly altered changes in VE-cadherin
association are marked (red: higher association, green: lower association, yellow: associated cytoskeletal proteins). Proteins of the VE-cadherin core
complex are depicted in blue. b HUVEC cell lysates were incubated with an anti-nestin (NES) antibody and isotype control (IgG) for crosslinking RNA
immunoprecipitation (CLIP). Enrichment of co-purified LASSIE RNA was detected by qRT-PCR and shown as percentage of the input fraction (n= 4;
unpaired t-test compared with IgG; p= 0.023). CLIP efficiency was analyzed by western blotting (WB), 1% of the lysate was used as a control and was
detected separately. c Endogenous LASSIE-protein complexes were captured from lysates of si ctr and anti-LASSIE (si LASSIE 1) treated HUVECs using an
LASSIE-AS oligonucleotide. RNA-antisense purifications were immunoblotted for nestin (n= 3; unpaired t-test; p= 0.022). d, e HUVECs were treated with
anti-LASSIE or ctr GapmeR (gap). Protein interaction of VE-cadherin and nestin was analyzed by proximity ligation assay (PLA). Each PLA event (white) is
indicative for protein interaction. Cells were immunostained for VE-cadherin (green), nuclei were stained with DAPI (blue). d Representative images are
shown. Scale bars are 20 µm. e PLA events were counted per image (n= 20 (gap ctr), n= 19 (gap LASSIE 1; p < 0.0001), n= 21 (gap LASSIE 2; p < 0.0001)
over three independent experiments; one-way ANOVA (compared with gap ctr)) (*p < 0.05; **p < 0.01; ***p < 0.001).
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this hypothesis, we analyzed the distribution of nestin in LASSIE-
silenced HUVECs by immunofluorescence. The nestin network
appeared more contracted and was less connected to the cell
membrane after silencing of LASSIE in comparison to control
cells, as quantified by co-localization analysis (Supplementary
Fig. 6e, f).
Next, we analyzed fluorescence recovery after photo bleaching
(FRAP) of LASSIE-silenced HUVECs expressing GFP-labeled
VE-cadherin, with the hypothesis that LASSIE-controlled cytos-
keleton association affects VE-cadherin mobility. This assay
revealed a faster recovery of the bleached linear junctional area
(Fig. 6a, b), suggesting a higher mobility of VE-cadherin in
LASSIE-silenced cells, which is indicative of decreased association
with the cytoskeleton.
To assess the involvement of the cytoskeleton and the role of
LASSIE in shear stress sensing and barrier function, we used
pharmacological inhibitors to disrupt the cytoskeleton. Since
there are no inhibitors to specifically disrupt IFs, we used
Nocodazole, which effectively disrupts both the MT and IF
networks35, and analyzed the effect on barrier function.
Nocodazole treatment drastically decreased endothelial barrier
integrity, as previously described36. The barrier was recovered
within 4 h and even improved compared with before Nocodazole
treatment. However, barrier recovery after Nocodazole treatment
was incomplete in the absence of LASSIE (Fig. 6c–e). LASSIE
knockdown did not affect recovery of the MT network per se, as
analyzed by immunofluorescence (Supplementary Fig. 7), indi-
cating that rather the interaction between the MT cytoskeleton
and the barrier function-controlling cell–cell junctions is
regulated by LASSIE. To more specifically address the role of
the IF network in the LASSIE-controlled regulation of shear stress
sensing and barrier function, we next used siRNA-mediated
silencing of the IF protein nestin (Supplementary Fig. 8a–c). Loss
of nestin did not reduce endothelial barrier function (Supple-
mentary Fig. 8d), indicating that LASSIE-mediated barrier
regulation is controlled by the MT cytoskeleton. However,
silencing of nestin resulted in loss of cell alignment in response
to flow (Fig. 6f, g), similar to LASSIE loss-of-function. These
results propose a crucial role of LASSIE in connecting the nestin
IF system to AJs and thereby stabilizing AJs. This connection and
the presence of LASSIE and nestin are essential for normal shear
stress sensing in ECs.
Discussion
This study identifies the shear stress-induced lncRNA LASSIE as
a crucial regulator of shear stress sensing and barrier function in
ECs. Its association with protein complexes that are involved in
endothelial junctions like PECAM-1 and γ-catenin as well as IF
protein nestin, together with loss of interaction between VE-
cadherin and cytoskeleton-associated proteins, indicate a crucial
role of LASSIE in the cytoskeletal association to endothelial
junctions. Indeed, silencing of LASSIE affected the stabilization of
AJs by the cytoskeleton and thereby barrier function and shear
stress responsiveness. Our results point out the importance of
intact AJ stabilization through the IF cytoskeleton for normal EC
d
cba
Barrier
disruption
Barrier
recovery
e f g
si ctr si NES
Flow direction
si ctr
si LASSIE 1
si LASSIE 2 
gap ctr
gap LASSIE 1
gap LASSIE 2 
si c
tr
si L
AS
SIE
1
si L
AS
SIE
2
0
20
40
60
80
H
al
f-t
im
e
(s
)
***
**
si c
t r
si N
ES
0
30
60
90
120
***
M
aj
or
 c
el
l a
xi
s 
an
gl
e 
( °
)
gap
ctr
gap
LAS
SIE
1
gap
LAS
SIE
2
0
50
100
150
B
ar
rie
rr
ec
ov
er
y
(n
or
m
al
iz
ed
to
un
tre
at
ed
)
*
**
**
**
gap
ctr
gap
LAS
SIE
1
gap
LAS
SIE
2
2
4
6
R
ec
ov
er
y
sl
op
e 
(Ω
*c
m
2 /h
)
0 1 2 3 4
0
2
4
6
8
10
Time (h)
B
ar
rie
rf
un
ct
io
n 
(Ω
*c
m
2 )
0 50 100 150 200 250 300
0.00
0.25
0.50
0.75
1.00
1.25
Time (s)
Fl
uo
re
sc
en
ce
in
te
ns
ity
(n
or
m
al
iz
ed
)
Fig. 6 LASSIE regulates barrier function and shear stress sensing by stabilizing adherens junctions. a, b VE-cadherin-GFP overexpressing HUVECs were
transfected with anti-LASSIE or ctr siRNA. Fluorescence recovery after photo bleaching (FRAP) was performed at junctional regions. a Fluorescence
intensity is plotted against time. b Half-time was quantified as 50% of the respective plateau levels determined by nonlinear regression (n= 22 (si ctr),
n= 26 (si LASSIE 1; p < 0.0001), n= 24 (si LASSIE 2; p= 0.0019)) over two independent experiments; one-way ANOVA (compared with si ctr).
c–e HUVECs were treated with anti-LASSIE or ctr GapmeR and stimulated with microtubules destabilizing Nocodazole (350 nM) at 72 h post transfection.
Barrier integrity was assessed by ECIS at 400 Hz. d The recovery slope was determined for a period of 1 h post stimulation (n= 3; one-way ANOVA;
compared with gap ctr: p= 0.0044 (gap LASSIE 1); p= 0.0035 (gap LASSIE 2)). e Barrier recovery was analyzed by normalizing Nocodazole stimulated
to untreated condition, 4 h post stimulation (n= 3; one-way ANOVA; compared with gap ctr: p= 0.0426 (gap LASSIE 1); p= 0.0012 (gap LASSIE 2)).
f, g HUVECs were treated with anti-nestin (NES) or ctr siRNA and exposed to laminar shear stress (20 dyn/cm2 for 48 h). f Representative bright field
images are shown. Scale bars are 400 µm. g Shear stress-induced cell alignment was quantified by determining the angle of the major cell axis (n= 414
(si ctr), n= 412 (si NES) over two independent experiments; unpaired t-test: p < 0.0001) (*p < 0.05; **p < 0.01; ***p < 0.001).
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function, mediated by the lncRNA LASSIE (Supplementary
Fig. 8g).
Like many shear stress-induced genes, LASSIE expression is
KLF2-dependent (Fig. 1b, c). KLF2 is a well-described tran-
scription factor that is responsible for atheroprotective gene
transcription in response to LSS1–3. Knockdown of KLF2 in
HUVECs exposed to LSS did not completely abolish LASSIE
expression (Fig. 1c), we therefore cannot exclude other tran-
scription factors like KLF4 to be involved in the transcriptional
regulation of LASSIE. Other lncRNAs are described to display
shear stress-dependent expression37,38. Most lncRNAs are poorly
evolutionary conserved on sequence level and are hypothesized to
display locus or secondary structure conservation39. In this
study, we identified a locus-conserved zebrafish homologue of
LASSIE. Although shear stress-dependent expression of LASSIE
(Fig. 1d, e) indicates functional conservation between human and
zebrafish, further studies are required.
We identified the IF protein nestin as well as the AJ compo-
nents PECAM-1 and γ-catenin as LASSIE interaction partners
(Figs. 3c, 5b, Supplementary 1). Little has been described about
the function of nestin in ECs. However, PECAM-1 is described to
act as a shear stress sensor through association with vimentin IF,
most likely via γ-catenin14,16. In this context, silencing of
vimentin has been previously described to reduce the mechanical
resistance to flow in immortalized human bone marrow ECs40.
Furthermore, vimentin is localized in parallel to MT in ECs41 and
reported to regulate barrier function in vivo42 and in cultured rat
pulmonary microvascular ECs43. In HUVECs, silencing of
vimentin alone did not affect the cell alignment in the direction of
flow, likely due to compensation of other IF proteins (Supple-
mentary Fig. 8e, f). In contrast, silencing of either LASSIE or
nestin did drastically disturb the cell alignment in the direction of
flow (Figs. 4g, 6f, g). This study describes the IF protein nestin to
be associated with EC junctions and to be involved in shear stress
sensing. The interaction of VE-cadherin and nestin is dependent
on RNAs, as VE-cadherin co-immunoprecipitation with a nestin
antibody was decreased in the presence of RNase A (Supple-
mentary Fig. 6c). More specifically, the absence of LASSIE
induces the dissociation of the VE-cadherin-nestin complex
(Fig. 5a, d, e), suggesting that LASSIE mediates the attachment of
IF protein nestin to AJs, essential for normal shear stress sensing.
Our results suggest that LASSIE is a crucial component of EC-
cell junction regulation by stabilizing AJs through IF and MT
networks. Interaction of both cytoskeletal components with VE-
cadherin was decreased in the absence of LASSIE, as shown by
MS of VE-cadherin immunoprecipitates (Fig. 5a). Furthermore,
FRAP of GFP-labeled VE-cadherin was enhanced in LASSIE-
silenced HUVECs due to increased VE-cadherin mobility (Fig. 6a,
b). Strikingly, nestin and vimentin seem not to play an essential
role in endothelial barrier resistance (Supplementary Fig. 8d).
This suggests that LASSIE-induced barrier stabilization is rather
mediated through the interaction of the MT cytoskeleton and the
barrier function-controlling cell–cell junctions, as barrier recovery
after Nocodazole treatment was incomplete in the absence of
LASSIE (Fig. 6c–e). Crosstalk mechanisms between IF and MT
have been described before35,44. Compensation by the MT net-
work might thus account for the mild effect on barrier function
induced by silencing of IFs. A clear distinction between a MT-
and IF-mediated mechanism is consequently challenging and it
cannot be excluded that the dissociation of either one of the
cytoskeletal components might be a secondary effect due to
crosstalk mechanisms. In short, this study indicates that LASSIE
regulates barrier function by directly affecting the composition of
junctional/cytoskeletal complexes.
In ECs, the lncRNA SENCR has recently been described to
regulate VE-cadherin internalization through interaction with
CKAP438. Interestingly, in our study CKAP4 was purified with an
anti-LASSIE oligonucleotide (Supplementary 1), likely an indirect
interaction. However, we did not observe changes in the inter-
action between VE-cadherin and CKAP4 (Supplementary 3) and
LASSIE does not regulate VE-cadherin internalization (Supple-
mentary Fig. 5e), indicating distinct mechanisms by which these
lncRNAs regulate barrier function.
Functional endothelial junctions are indispensable for cell
homeostasis and junctional defects lead to cell apoptosis45.
Accordingly, cell survival was impaired in LASSIE-silenced
HUVECs, likely evoked by impaired cell–cell interactions, ulti-
mately leading to impaired angiogenic sprouting (Fig. 2). Similar
effects were observed after silencing VE-cadherin in HUVECs
resulting in a decrease in continuous sprout formation (data not
published). The VE-cadherin complex can indirectly regulate
transcription as its binding partners β-, γ-, and p120-catenin can
translocate to the nucleus for downstream transcriptional reg-
ulation, as described to be mediated by the lncRNA CYTOR46.
Although our results indicate an influence of LASSIE on AJs,
silencing of LASSIE does not influence the composition of the
VE-cadherin-catenin complex (Fig. 5a, Supplementary 3). In
accordance, LASSIE does not greatly affect global gene expression
(Supplementary Fig. 4a).
LASSIE localizes close to the ER and co-localizes with junc-
tional proteins PECAM-1, VE-cadherin, and γ-catenin (Fig. 3e, f).
Bioinformatics pathway analysis of LASSIE interacting proteins
indicate a possible role of LASSIE in protein processing in the ER
and vesicle mediated transport to the plasma membrane (Sup-
plementary 2, Supplementary Fig. 8g). This study thus suggests
that LASSIE regulates protein domain assembly between junction
proteins and nestin at the ER. Of note, LASSIE silencing does not
affect PECAM-1 or VE-cadherin protein levels or cell membrane
localization (Supplementary Fig. 5d, e). We therefore concluded
that this complex is transported to the plasma membrane in a
functionally incomplete state resulting in impaired endothelial
barrier function and shear stress sensing in the absence of LAS-
SIE. However, future studies are required to specify the impact of
LASSIE on protein complex assembly at the ER.
Some studies already propose a cytoskeleton-associated role for
lncRNAs47. Here we describe a lncRNA that functions as a direct
link between the cytoskeleton and AJs, thereby regulating endo-
thelial barrier and shear stress sensing.
In conclusion, this study provides evidence that the shear
stress-regulated lncRNA LASSIE acts as a structural component
of protein complexes. LASSIE is crucial for the cytoskeletal
association to AJs and these data highlight LASSIE as a compo-
nent in the regulation of endothelial barrier function and shear
stress response.
Materials and methods
Cell culture. HUVECs and human umbilical artery endothelial cells (HUAECs)
were purchased from Lonza and cultured in EC medium ECM (ScienCell) sup-
plemented with 5% fetal calf serum (FCS, ScienCell), 1% penicillin/streptomycin
(ScienCell) and endothelial growth supplement (ScienCell) or endothelial basal
medium (EBM; Lonza) supplemented with EGM SingleQuots (Lonza), and 10%
FCS (Invitrogen). Microvascular endothelial cells were isolated from pleura-free
peripheral lung tissues and pulmonary artery endothelial cells from rings of the
arteria pulmonalis, as described previously48 and cultured in ECM. Cells were used
for experiments until passage four. Cell numbers were determined by an automated
cell counter (Countess II FL, Invitrogen).
HEK293T cells were purchased from ATCC and cultured in Dulbecco’s
modified Eagle medium (Lonza) supplemented with 10% FCS, 1% penicillin/
streptomycin, 1% L-glutamin, and 1% pyruvate. Cells were used until passage 35
for production of lentiviral particles.
All cell types were cultured at 37 °C in a 5% CO2 atmosphere and tested
negative for mycoplasma.
Antibodies, oligonucleotides, and inhibitors. Information on antibodies and
oligonucleotides used in this study is provided in Supplementary Tables 1–2.
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Primers, DNA oligonucleotides, and siRNAs were purchased from Sigma-Aldrich,
LNA GapmeRs from Exiqon, and 2′O-Me-RNA probes from Integrated DNA
Technologies. Protease and phosphatase inhibitors were purchased from Roche
and RNase inhibitor from Thermo Scientific.
Cell transfections and stimulations. HUVECs were transfected at 60–70% con-
fluence with LNA GapmeRs or siRNAs using Lipofectamine RNAiMax (Thermo
Scientific) according to the manufacturer’s protocol. Nocodazole (350 nM, Sigma-
Aldrich) and Z-VAD-FMK (50 µM, Selleckchem) were diluted in the respective
medium for stimulation of HUVECs.
5′ and 3′ RACE (rapid amplification of cDNA ends). LncRNA transcript variants
were identified by 5′ and 3′ RACE using the SMARTer™ RACE cDNA Amplifi-
cation Kit (Clontech) according to the manufacturer’s protocol. Briefly, RNA of
KLF2 overexpressing HUVECs was reverse transcribed using specific 5′ or 3′ end
binding primers. Obtained cDNA was used as a template for 5′ and 3′ RACE PCRs
with gene-specific primers. Gel-purified RACE PCR products were sequenced
directly or cloned into pJET1.2/blunt vector (CloneJET PCR cloning kit, Thermo
Scientific) according to the manufacturer’s protocol and sequenced subsequently.
Sequencing was performed by Eurofins Genomics
Lentiviral constructs. For lentiviral overexpression, the LASSIE transcript variant
1 sequence (Supplementary Table 3) was cloned into pLenti4/V5-DEST™ Gateway™
vector (Thermo Scientific). Lentiviral particles were generated by transfection of
HEK293T cells with viral packaging plasmids pCMVΔR8.91, pMD2.G, and
pLenti4/V5-DEST-LASSIE plasmid using GeneJuice® Transfection Reagent (Merck
Millipore). Empty pLenti4/V5-DEST™ was used as a control. Supernatants were
collected 48 and 72 h after transfection and concentrated by centrifugation (690 × g,
4 °C) using Amicon Ultra-15 Centrifugal Filter Units (Merck Millipore). Long-term
overexpression of VE-Cadherin-GFP49 or KLF2 as well as shRNA mediated
silencing of KLF21 was performed as previously described. HUVECs treated with
lentivirus for LASSIE overexpression were washed with medium 24 h after virus
transduction. Experiments were performed 72 h after virus transduction.
RNA isolation and RT-qPCR. Total RNA from cultured HUVECs was isolated and
DNase digested using the Direct-zol RNA miniprep kit (Zymo Research). 1 µg
RNA was reverse transcribed using the iScript™ cDNA Synthesis Kit (Bio-rad).
cDNA was diluted to a final concentration of 5 ng/µl (assuming a transcription
efficiency of 100%) and used as a template for qPCR (iQ™ SYBR Green Supermix,
Bio-rad) performed in a C1000 Touch™ Thermal Cycler (Bio-rad). mRNA
expression levels of human RPLP0 and glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) were used for normalization and relative expression levels were subse-
quently calculated as values of 2−ΔCt.
Nuclear and cytoplasmic cell fractionation. Nuclear and cytoplasmic fractions
were separated as previously described50. Briefly, HUVECs were collected by cell
scraping and centrifugation (5 min at 500 × g, 4 °C). Cell pellets were treated with
cytoplasmic lysis buffer (10 mM Tris-HCl pH 7.5, 10 mM NaCl, 3 mM MgCl2,
0.5% Nonidet P-40 (NP-40)) and incubated on ice for 5 min. Cells were spun down
and supernatants were collected as cytoplasmic fraction. Pelleted nuclei were
washed with cytoplasmic lysis buffer and incubated with nucleic lysis buffer
(10 mM Tris-HCl pH 7.5, 150 mM NaCl, 3 mM MgCl2) for 5 min on ice. Cyto-
plasmic fraction and pelleted nuclei were treated with Trizol and RNA was
extracted from both fractions. Equal volumes of RNA were used for cDNA
synthesis.
Shear stress. In all, 8 × 104 HUVECs were seeded in μ-slides I0.4 (Ibidi) and
allowed to attach for 6 h. Cells were exposed to laminar (20 dyn/cm2 for 72 h) or
oscillatory shear stress (20 dyn/cm2 for 14 h), controlled by the Ibidi perfusion
system. The same cell number was seeded per well of a 24-well plate as static
control. GapmeR/siRNA-treated cells were seeded in shear slides 20 h after
transfection and were exposed to LSS for 48 h.
Shear stress analyses of bright field images were conducted with the straight line
tool in ImageJ. Major and minor axes were measured for calculation of the length
ratio. For analysis of the cell angle, cells with a length ratio smaller than 1 were
excluded. The angle of the major axis of more than 600 cells per condition was
compared from two independent experiments. Fluorescence images were used to
quantify the gap area between cells by measuring the cell free area in ImageJ.
Intracellular calcium concentration [Ca2+]I in response to shear stress was
determined as described previously51. Briefly, HUAECs were seeded in a
microfluidic plate (Fluxion) and loaded with Fluo-4 AM (Molecular Probes). Cells
were exposed to LSS (3; 10 and 15 dyn/cm2) generated by the BioFlux 200 system
(fluxion). [Ca2+]I was determined as fluorescence intensity (RFU, relative units).
[Ca2+]I peak induction was quantified by setting individual baselines for each
condition and each shear stress rate (RFU (peak)–RFU (baseline)).
RNA sequencing. RNA sequencing data of HUVECs exposed to LSS was obtained
from the NCBI GEO database (accession number GSE54384)28.
Exon array. Global gene expression was analyzed by Affymetrix Human Exon 1.0
ST Array. Briefly, RNA was isolated from HUVECs treated with control or anti-
LASSIE GapmeR for 48 h as described above. cDNA synthesis, labeling, hybridi-
zation, and scanning was performed by Atlas Biolabs GmbH (Berlin). Microarray
data were normalized by quantile normalization. The exon array data have been
deposited in the NCBI GEO database under the accession number GSE146110.
In vitro sprouting assay. EC function was studied in a spheroid sprouting assay,
as previously described52. Briefly, GapmeR-treated HUVECs (24 h post transfec-
tion) were seeded in ECM containing methylcellulose (20%) into a non-adherent
round-bottom 96-well plate to allow one spheroid to be formed per well. Spheroids
were collected after 24 h and embedded into a collagen type I gel (BD Biosciences)
in a 24-well plate. After polymerization (30 min), ECM (VEGF, 50 ng/ml) was
added on top and the plate incubated for 24 h.
EC spheroids were analyzed by bright field microscopy (Axio Observer Z1.0
microscope, Zeiss, magnification: 10×) using the Axio Vision 4.8 analysis software
(Carl Zeiss). Cumulative and discontinuous sprout length of each spheroid was
measured. Subtraction of the cumulative sprout length from the maximal distance
of the migrated cell was defined as discontinuous sprout length.
Cell apoptosis assays. Cell apoptosis was assessed using the Apo-ONE® Homo-
geneous Caspase-3/7 Assay (Promega) according the manufacturer’s protocol.
HUVECs were treated with pan-caspase inhibitor Z-VAD-FMK (50 µM in DMSO;
Selleckchem) for 24 h and with Staurosporine (50 nM in DMSO; Sigma-Aldrich;
final DMSO concentration 0.1%) for 4 h prior to measurement. Control cells were
treated with 0.1% DMSO.
Binding of Annexin V to the cell surface and DNA intercalation of 7-AAD was
analyzed by flow cytometry. Cells were trypsinized and spun down (5 min, 500 × g,
4 °C). Pellets were washed with 1× Annexin V binding buffer (BD Biosciences). 7-
AAD (BD Biosciences) and the anti-Annexin V-V450 antibody (BD Biosciences)
were added (1:50 in binding buffer) and incubated for 15 min at RT in the dark.
Apoptosis was quantified by flow cytometry using a FACS Canto II device (BD
Biosciences).
Cell proliferation assays. Cell proliferation was assessed using the Click-iT® EdU
Microplate Assay (Invitrogen) according to the manufacturer’s protocol and by cell
counting. Transfected HUVECs were counted at 24, 48, and 72 h using the
Nucleocounter 2000 (ChemoMetec A/S).
Flow cytometry. Cell surface expression of VE-Cadherin and PECAM-1 was
analyzed in HUVECs by flow cytometry. Briefly, transfected HUVECs were
detached with Accutase and washed in cold incubation buffer (0.1% BSA in PBS).
Cells were blocked (5% BSA in PBS) for 30 min on ice and subsequently incubated
with fluorophore-labeled antibodies for 30 min on ice. Protein cell surface
expression was analyzed using a FACSCalibur™ device (BD Biosciences).
Scratch wound healing assay. Cell migration chambers (Ibidi) were placed in a
24-well tissue culture dish. Cells were seeded into each half-chamber and grown
overnight. After removal of the inserts, lateral cell migration was visualized by
bright field microscopy (Axio Observer Z1.0 microscope, Zeiss, magnification:
10×). Pictures were taken at 0, 3, 6, and 8 h after removal of the inserts. Quanti-
tative assay analysis was performed in ImageJ. The area covered by cells was
determined for the indicated time points.
Endothelial integrity measurement. Endothelial barrier function was measured
by the ECIS system (Applied BioPhysics) as described previously53. Briefly, 40,000
HUVECs (24 h post transfection) were seeded per well of a gelatin-coated (1%)
96W1E+ PET plate (Applied BioPhysics). The pan-caspase inhibitor Z-VAD-
FMK (50 µM in DMSO; Selleckchem; final DMSO concentration 0.1%) was added
4 h post transfection and during seeding of transfected cells in the ECIS plate.
Control cells were treated with 0.1% DMSO. Endothelial barrier integrity was
analyzed after 48 h when cells formed a stable monolayer. Barrier resistance (Rb)
was measured by applying an alternating current of 400 Hz resulting in a potential
which is detected by the ECIS instrument Zθ (Applied BioPhysics), impedance is
determined according to Ohm’s law. In all, 100,000 HUVECs were seeded in an
8W1E ECIS array (Applied Biophysics) for analyzing cell migration by inducing
cell wounding through lethal electroporation. Wound repair was observed over a
period of 4 h, the area under the impedance curve (4000 Hz) was calculated.
Transwell assay. Endothelial barrier integrity was analyzed by HRP passage
through the endothelial monolayer. Overall, 100,000 HUVECs (24 h post trans-
fection) were seeded into gelatin-coated (1%) ThinCerts™ cell culture inserts (pore
sixe: 3.0 mm, Greiner Bio-one). Forty-eight hours post transfection, 5 mg/ml HRP
(Sigma-Aldrich) was added to the upper compartment for 1 h. HRP passage was
determined by absorption measurements (450 nm) of the lower and upper com-
partment after adding TetraMethylBenzidine (Merck Millipore) and sulfuric acid.
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RNase H accessibility assay. Accessibility of LASSIE RNA was assessed as pre-
viously described27. HUVECs were lysed (50 mM Tris-HCl pH 8, 150 mM NaCl,
0.5% NP-40, protease inhibitor) for 30 min on ice. Cell lysates were cleared by
centrifugation (10 min, 16,000 × g, 4 °C) and supernatants were adjusted to a
volume of 1 ml (50 mM Tris-HCl pH 8, 60 mM NaCl, 75 mM KCl, 3 mM MgCl2,
10 mM DTT, 40 U RNase inhibitor). 100 pmol of DNA LASSIE 1 oligonucleotide
was incubated with 100 µl cell lysate for 2 h at 4 °C under continuous rotation. 2.5
U RNase H (New England Biolabs) was added and incubated for 20 min at 37 °C
(350 rpm). Finally, Trizol was added and RNA accessibility was analyzed by RT-
qPCR.
RNA-antisense purification. RNP complexes were captured as previously
described27. In brief, HUVECs (one confluent 15 cm dish/condition) were lysed
(50 mM Tris-HCl pH 8, 150 mM NaCl, 1 mM EDTA, 0.5% NP-40, protease
inhibitor) for 30 min on ice. Cell lysates were cleared by centrifugation (10 min,
16,000 × g, 4 °C), adjusted to a volume of 1 ml (50 mM Tris-HCl pH 8, 150 mM
NaCl, 75 mM KCl, 3 mM MgCl2, 10 mM DTT, 80 U RNase inhibitor) and pre-
cleared for 2 h at 4 °C with 50 µl pre-blocked (glycogen and yeast tRNA (0.2 mg/ml,
Sigma-Aldrich) for 2 h at 4 °C) streptavidin C1 beads (Thermo Scientific). Equal
amount of protein lysates were used for siRNA-treated cells. RNP complexes were
isolated by incubating lysates with 100 pmol desthiobiotin-coupled 2′O-Me-RNA
anti-LASSIE and non-targeting control oligonucleotides for 1 h at 37 °C. RNP-
oligonucleotide complexes were captured using 100 μl pre-blocked beads for 1 h at
37 °C. Beads were washed four times (lysis buffer containing 0.05% NP-40) fol-
lowed by Biotin (100 μM) elution for 1 h at RT. Eluates were analyzed by RT-qPCR
and MS. For MS analysis and protein enrichment analysis by western blotting of
siRNA-treated cells, beads were washed twice (20 mM Tris-HCl pH 7.5, 10 mM
NaCl, 1 mM EDTA, 0.05% NP-40) and once with the same buffer not containing
NP-40 following RNA purification. Samples for MS were treated as described
above. For protein enrichment analysis by western blotting, beads were treated with
5× sample buffer (312.5 mM Tris pH 6.8, 50% glycerol, 0.37 mM Bromphenol blue,
347 mM SDS, 2.5% β-mercaptoethanol).
Crosslinking RNA immunoprecipitation (CLIP). HUVECs (one confluent 15 cm
dish/condition) were UV-crosslinked (2 × 50 mJ/cm2, Analytic Jena) and lysed
(PECAM-1 CLIP: 50 mM Tris pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.5% Triton X-
100, 0.5% Deoxycholate, 1 mM Na2VO4, 2 mM PMSF, protease inhibitor, 80 U
RNase inhibitor; NES CLIP: 50 mM Tris pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.5%
NP-40, protease inhibitor) for 30 min on ice. Cell lysates were cleared by cen-
trifugation (10 min, 16,000 × g, 4 °C) and supernatants were adjusted to a volume
of 1 ml (50 mM Tris, pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM DTT). For
immunoprecipitation, 1 ml cell lysate was incubated with anti-PECAM-1, anti-
nestin antibody or control IgG overnight at 4 °C. RNP complexes were captured
with 50 µl Dynabeads protein G (Thermo Scientific) by incubation at 4 °C for 4 h.
Beads were washed three times (20 mM Tris pH 7.5, 10 mM NaCl, 1 mM EDTA)
and proteinase K (New England Biolabs) digested (200 mM Tris pH 8, 300 mM
NaCl, 2% SDS, 25 mM EDTA, 6.4 U proteinase K) for 30 min at 55 °C. RNA was
recovered by phenol/chloroform/isoamyl extraction and RNP binding was quan-
tified by RT-qPCR.
Immunoprecipitation. HUVECs (48 h post transfection) were lysed (25 mM Tris-
HCl pH 7.5, 100 mM NaCl, 10 mM MgCl2, 1 mM EDTA, 10% glycerol, 1% NP-40,
protease and phosphatase inhibitors) for 15 min on ice. For immunoprecipitation,
0.7 mg cell lysate was incubated with anti-VE-Cadherin antibody and 50 µl
Dynabeads protein G (Thermo Scientific) for 1.5 h at 4 °C. Beads were washed with
lysis and wash buffer (25 mM Tris-HCl pH 7.5, 100 mM NaCl, 10 mM MgCl2) and
finally analyzed by MS. Proteins with a sequence coverage higher than 4% were
used for further quantification.
For co-immunoprecipitation of VE-cadherin using an anti-nestin antibody,
100 µg/mL RNase A (Thermo Scientific) was added to the lysis buffer and the IP
reaction to analyze the involvement of RNAs on the studied interaction.
Mass spectrometry. RNA pulldown eluates and immunoprecipitation beads were
analyzed by liquid chromatography/MS using a Q Exactive Plus (Thermo Scien-
tific) mass spectrometer equipped with an ultra-high performance liquid chro-
matography unit (Dionex Ultimate 3000, Thermo Scientific) and a Nanospray Flex
Ion-Source (Thermo Scientific). Data analysis was performed in MaxQuant
1.5.3.3054, Perseus 1.5.6.055, and Excel (Microsoft Office 2013). The MS proteomics
data have been deposited to the ProteomeXchange Consortium via the PRIDE56
partner repository with the dataset identifier PXD018724 (LASSIE-AS purification,
Fig. 3c), PXD018734 (LASSIE-RNA purification, Supplementary Fig. 6d),
PXD018725 (VE-Cadherin IP, Fig. 5a).
Immunofluorescence. HUVECs were grown on gelatin (1%) coated coverslips at
static condition or exposed to LSS. Cells were fixed in paraformaldehyde (3.7%) for
10 min at RT, permeabilized in Triton X-100 (0.1%) for 10 min at RT, blocked in
BSA (2%) for 1 h at RT, and incubated with primary antibodies (in 2% BSA)
overnight at 4 °C. Cells were stained with fluorophore conjugated secondary
antibodies (Life technologies) and Acti-stain 555 phalloidin (Cytoskeleton) for 1 h
in the dark. Nuclei were labeled with DAPI (Invitrogen). All washing steps were
performed in HBSS with calcium and magnesium (Gibco), which was used for
reagent dilution. Cells were imaged by confocal microscopy (Nikon A1R) using a
63 × 1.4 NA oil-immersion objective.
FRAP bleaching experiments were performed in HUVECs, virally transduced
with VE-cadherin-GFP49. Cells were seeded in Lap-Tek (Thermo Scientfic)
chamber slides and FRAP experiments were performed 48 h later with 488 nm laser
illumination. Fluorescence recovery was measured by time-lapse imaging (63 × 1.4
NA oil-immersion objective, Leica SP8) using 50 iterations after photo bleaching.
Fluorescence values were normalized to total fluorescence. Fluorescence recovery
half-time was time was quantified as 50% of the respective plateau levels
determined by nonlinear regression.
Fluorescence in situ hybridization. Subcellular localization of LASSIE was
assessed in HUVECs exposed to LSS using the ViewRNA ISH Cell Assay Kit
(Thermo Scientific) according to the manufacturer’s instructions. Briefly, cells were
fixed, permeabilized, blocked, and incubated with primary antibodies followed by
fluorophore conjugated secondary antibody incubation. Hybridization of a Type 1
LASSIE-specific ViewRNA probe set (targeting LASSIE transcript variant 1) was
performed at 40 °C for 3 h. The signal was increased in a sequential bDNA
amplification step. bDNA structures were detected by Alexa Fluor 546 dyes. A Type
6 probe set targeting b-Actin was used as a positive control, detected by Alexa Fluor
647. Nuclei were labeled with DAPI (Invitrogen) and finally analyzed by confocal
microscopy (Nikon A1R) using a 63 × 1.4 oil-immersion objective.
Co-localization analysis of LASSIE with different proteins was conducted in
ImageJ by creating a mask of the LASSIE and the respective protein signal. Co-
localization of the LASSIE signal was determined by overlaying both masks and
counting the co-localizing particles.
Proximity ligation assay. Protein–protein interactions were assessed using the
Duolink® PLA (Sigma-Aldrich) according to the manufacture’s protocol In brief,
HUVECs were grown on gelatin-coated coverslips (1%), fixed in paraformaldehyde
(3.7%) for 10 min at RT and permeabilized in Triton X-100 (0.1%) for 10 min at
RT. Cells were blocked (1 h at 37 °C) and incubated with primary antibodies
overnight (4 °C). Cells were incubated with the respective PLA probes for 1 h at
37 °C and subsequent ligation was performed for 30 min (37 °C). The amplification
with polymerase was allowed for 100 min (37 °C) and cells were stained with an
anti-VE-Cadherin antibody, nuclei were labeled with DAPI (Fluoromount-G with
DAPI, Invitrogen). Protein–protein interactions were detected with 546 nm laser
illumination by confocal microscopy (Nikon A1R) using a 63 × 1.4 oil-immersion
objective. PLA events were counted in ImageJ.
Western blot. HUVECs (48 h post transfection) were washed with ice cold PBS
and lysed in RIPA Buffer (Sigma-Aldrich) supplemented with proteinase and
phosphatase inhibitor (25 mM NaF, 10 mM Na2VO4, 10 mM Na2PO7, 5 mM
β-glycerophosphate disodium salt hydrate) for 15 min on ice. Protein concentra-
tions were determined by Bradford assays (Bio-rad) and lysates were treated with
5× sample buffer (312.5 mM Tris pH 6.8, 50% glycerol, 0.37 mM Bromphenol blue,
347 mM SDS, 2.5% β-mercaptoethanol). Equal protein amounts were separated by
SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose mem-
branes (GE Health care). Membranes were blocked in BSA (5% in TBS-T) for 1 h.
Primary antibodies were diluted in blocking solution and incubated overnight
(4 °C). GAPDH was used as a loading control. HRP-conjugated secondary anti-
mouse/rabbit antibodies (Dako) were incubated for 1 h at RT. ECL detection
(Merck Millipore) was used for visualization with the Amersham Imager 600 (GE
Health Care). Band intensities were quantified in ImageQuant TL (GE
Health Care).
Morpholino studies in zebrafish. Zebrafish embryos were raised and maintained
at 28.5 °C in E3 egg water. Fertilized fli1a:EGFP transgenic embryos were collected
immediately after spawning. Morpholino oligonucleotides (Gene Tools) targeting
tnnt2a and a control sequence (4 ng) were injected into one-cell stage fli1a:EGFP
transgenic embryos57. Embryos were euthanized 72 hpf by MS-222, 20–30 embryos
were collected for one sample dissociation. Embryos were dissociated by col-
lagenase in HBSS at 28 °C for 15 min, reaction was stopped by adding three times
volume of 10% FCS. Cells were passed through a 40 µm cell strainer into a FACS
tube. Overall, 50,000 GFP positive cells were sorted as one sample for RNA iso-
lation and qPCR analysis. Experiments were repeated three times independently.
Expression of klf2a and BC091967 was examined by RT-qPCR.
All zebrafish husbandries were performed under standard conditions, and all
experiments were carried out in accordance with institutional (University of
Cologne) and national ethical and animal welfare guidelines. All animal procedures
conformed to EU Directive 86/609/EEC and Recommendation 2007/526/EC
regarding the protection of animals used for experimental and other scientific
purposes. The loss of function experiments using morpholinos was approved by
the Landesamt Für Natur, Umwelt und Verbraucherschutz Nordrhein-Westfalen
(LANUW NRW, Postfach 10 10 52, 45610 Recklinghausen) under the approval
number 84-02.04.2014.A295.
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Statistics and reproducibility. GraphPad 7 (GraphPad Software) was used for
statistical analyses. Comparison of two different conditions was analyzed by two-
tailed Student’s t test or Mann–Whitney, multiple comparisons were performed by
one-way or two-way ANOVA using Dunnett’s, Bonferroni, Holm’s–Sidak, Tukey’s,
or Kruskal–Wallis correction. Data are expressed as means ± SEM, p < 0.05 was
considered as statistically significant (*p < 0.05; **p < 0.01; ***p < 0.001). Outliers
were identified by Grubbs method. The sample size n states the number of inde-
pendent experiments, unless denoted otherwise. All results were reproduced in at
least three technically independent replicates.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
All data generated and analyzed during this study are available from the corresponding
author on reasonable request. Microarray data are deposited in the Gene Expression
Omnibus repository under the accession number GSE146110. Proteomics data are
deposited in the PRIDE archive under the accession numbers PXD018724, PXD018734,
and PXD018725. Source data are provided as Supplementary Data 5.
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